Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Small Biopsy Bottle No 2

The Small Biopsy Bottle No 2 test is used to collect tissue samples for histopathological analysis, aiding in the diagnosis of various conditions. Requires a doctor's prescription.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tissue sample collected into a Small Biopsy Bottle No 2.
Results
Results are typically available within 3 days. Confirm with the laboratory before booking.
Preparation
Confirm specific preparation instructions with your healthcare provider or the laboratory before the procedure.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Small Biopsy Bottle No 2 test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained weight loss
  • ✓Persistent pain
  • ✓Symptoms suggestive of genetic conditions
  • ✓Family history of genetic diseases
  • ✓Healthcare provider recommendation
  • ✓Tissue analysis for diagnosis
02

In plain language

What this test helps you understand

This test aids in the diagnosis of various conditions by allowing microscopic examination of tissue samples. It helps identify cellular abnormalities, genetic disorders, and malignancies.
The Small Biopsy Bottle No 2 test is a diagnostic tool used to collect tissue samples for laboratory analysis. This process, known as histopathology, allows medical professionals to examine tissue at a microscopic level to identify abnormalities, diagnose diseases, and understand underlying health conditions. This test is particularly useful in identifying genetic conditions and other pathologies.

This test involves collecting a small tissue sample, which is then preserved in a special bottle (No 2) for transport and analysis. The laboratory examines the cellular structure of the tissue to detect any signs of disease, such as genetic disorders or malignancies.

Individuals experiencing symptoms like unexplained weight loss, persistent pain, or other health concerns potentially related to genetic conditions may be advised to undergo this test. It is also recommended for individuals with a family history of certain genetic diseases or those specifically advised by their healthcare provider.

Taking this test can provide several benefits, including accurate diagnosis, guidance for treatment planning, early detection of health issues, and providing clarity regarding a patient's health status.

Results are typically available within 3 days. It is crucial to discuss the results with your healthcare provider to understand their meaning and any necessary follow-up actions.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm specific preparation instructions with your healthcare provider or the laboratory before the procedure.
SampleTissue sample collected into a Small Biopsy Bottle No 2.
MethodologyHistopathological examination of tissue sample.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The accuracy of the test depends on the quality and representativeness of the tissue sample collected. Results may require correlation with other clinical findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A biopsy is a procedure to remove a small piece of tissue for examination under a microscope.
This specific bottle is designed for preserving tissue samples for histopathological analysis.
Yes, this test requires a doctor's prescription.
Results are typically available within 3 days, but confirm the exact turnaround time with the laboratory.
You should discuss the results with your healthcare provider to understand their implications and any necessary next steps.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp